Cerity Partners LLC

Position in FTRE — Fortrea Holdings Inc.

CIK 1566475 NEW YORK, NY

Position in FTRE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,442,215

+$687,232 QoQ

Shares Held

82,886

+3.4% QoQ

Ownership

0.087%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#96

of 334 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 3% Shared 28% None 68%

Healthcare · as of Jun 30, 2026

Cerity Partners LLC holds $426,228,183 across 139 Biotechnology names. FTRE ranks #28 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	255,874	$127,100,291
2	CORT	Corcept Therapeutics Inc	797,119	$69,309,495
3	HALO	Halozyme Therapeutics, Inc.	343,589	$26,892,710
4	REGN	Regeneron Pharmaceuticals, Inc.	39,274	$24,488,909
5	INCY	Incyte Corp	205,071	$23,246,847
6	EXEL	Exelixis, Inc.	377,130	$20,519,642
7	JAZZ	Jazz Pharmaceuticals plc	53,534	$12,900,087
8	RPRX	Royalty Pharma plc	180,772	$10,135,884

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,442,215	82,886	+3.4%	Shares	Sole	2026-08-14
2026-03-31	$754,983	80,147	+20.2%	Shares	Defined	2026-05-15
2025-12-31	$1,149,815	66,656	+4.6%	Shares	Sole	2026-02-11
2025-09-30	$536,421	63,708	-14.1%	Shares	Sole	2025-10-22
2025-06-30	$366,350	74,160	+156.0%	Shares	Sole	2025-08-13
2025-03-31	$218,731	28,971	+93.3%	Shares	Sole	2025-04-30
2024-12-31	$279,526	14,988	-1.0%	Shares	Defined	2025-02-13
2024-09-30	$302,860	15,143	+8.1%	Shares	Defined	2024-11-12
2024-06-30	$326,806	14,002	-12.4%	Shares	Sole	2024-08-13
2024-03-31	$641,918	15,992	+22.6%	Shares	Defined	2024-05-14
2023-12-31	$455,061	13,039	+31.9%	Shares	Sole	2024-01-26
2023-09-30	$282,583	9,884	-70.1%	Shares	Sole	2023-11-14
2023-06-30	$1,124,370	33,060	—	Shares	Other	2023-08-14
No filing history on record for this holder in this stock.